Comparison of relative and absolute rectal dose-volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients
- PMID: 30191285
- DOI: 10.1007/s00066-018-1365-4
Comparison of relative and absolute rectal dose-volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients
Abstract
Purpose: To compare relative and absolute dose-volume parameters (DV) of the rectum and their clinical correlation with acute and late radiation proctitis (RP) after radiotherapy (RT) for prostate cancer (PCa).
Patients and methods: 366 patients received RT for PCa. In total, 49.2% received definitive RT, 20.2% received postoperative RT and 30.6% received salvage RT for biochemical recurrence. In 77.9% of patients, RT was delivered to the prostate or prostate bed, and additional whole pelvic RT was performed in 22.1%. 33.9% received 3D-RT, and 66.1% received IMRT. The median follow-up was 59.5 months (18.0-84.0 months). The relative (in %) and absolute (in ccm) rectal doses from 20-75 Gy including the receiver operating characteristics curves (rAUC) from 30-65 Gy (in % and ccm) and several other clinical parameters were analyzed in univariate and multivariate analyses. We performed the statistical analyses separately for the entire cohort (n = 366), patients with (n = 81) and without (n = 285) pelvic RT, comparing RP vs. RP ≥ grade I.
Results: With the exception of the V50Gyccm (p = 0.02) in the univariate analyses for acute RP in the entire patient cohort, no absolute DV parameter (in ccm) was statistically significant associated with either acute or late RP. In the multivariate analyses, 3D-RT (p < 0.008) and rAUCV30-50 Gy% (p = 0.006) were significant parameters for acute RP for the entire cohort, and the V50Gy% (p = 0.01) was the significant parameter for patients with pelvic RT. The rAUCV40-50 Gy% (p = 0.004) was significant for RT to the prostate/prostate bed. Regarding the statistical analysis for late RP, the rAUCV30-65 Gy% (p = 0.001) was significant for the entire cohort, and rAUCV30-50 Gy% (p = 0.001) was significant for RT of the prostate/prostate bed. No parameter was significant in patients with pelvic RT.
Conclusion: Absolute DV parameters in ccm are not required for RT in PCa patients.
Keywords: Dose–volume parameter; Prostate cancer; Radiation proctitis; Radiotherapy.
Similar articles
-
Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.Strahlenther Onkol. 2020 Jul;196(7):617-627. doi: 10.1007/s00066-020-01590-3. Epub 2020 Mar 12. Strahlenther Onkol. 2020. PMID: 32166451 English.
-
Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy.Strahlenther Onkol. 2019 Feb;195(2):131-144. doi: 10.1007/s00066-018-1359-2. Epub 2018 Sep 4. Strahlenther Onkol. 2019. PMID: 30182246 English.
-
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24. doi: 10.1016/j.ijrobp.2004.06.018. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708249
-
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308. doi: 10.1016/j.ijrobp.2004.12.052. Int J Radiat Oncol Biol Phys. 2005. PMID: 16029785 Review.
-
Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy.Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1530-5. doi: 10.1016/j.ijrobp.2003.09.082. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050333 Review.
Cited by
-
A Ten-year-long Update on Radiation Proctitis Among Prostate Cancer Patients Treated With Curative External Beam Radiotherapy.In Vivo. 2021 May-Jun;35(3):1379-1391. doi: 10.21873/invivo.12390. Epub 2021 Apr 28. In Vivo. 2021. PMID: 33910815 Free PMC article. Review.
-
Regulatory T cells and cytotoxic T cells close to the epithelial-stromal interface are associated with a favorable prognosis.Oncoimmunology. 2020 Apr 14;9(1):1746149. doi: 10.1080/2162402X.2020.1746149. eCollection 2020. Oncoimmunology. 2020. PMID: 32363115 Free PMC article.
-
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition.Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1163-1173. doi: 10.1016/j.ijrobp.2023.07.002. Epub 2023 Jul 16. Int J Radiat Oncol Biol Phys. 2023. PMID: 37433374 Free PMC article.
-
Radioprotection of healthy tissue via nanoparticle-delivered mRNA encoding for a damage-suppressor protein found in tardigrades.Nat Biomed Eng. 2025 Aug;9(8):1240-1253. doi: 10.1038/s41551-025-01360-5. Epub 2025 Feb 26. Nat Biomed Eng. 2025. PMID: 40011582
-
Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose.Qual Life Res. 2021 Feb;30(2):437-443. doi: 10.1007/s11136-020-02639-7. Epub 2020 Oct 9. Qual Life Res. 2021. PMID: 33034812 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical